Table 2.

Recommended first-line and alternative ART regimens in China’s national guidelines for HIV/AIDS treatment (2005–2018)

Guidelines	2005 [13]	2011 [7]	2015 [14]	2018[12]
First-line	AZT(d4T) + 3TC+ EFV(NVP)	TDF + 3TC + EFV +LPV/r +RAV or ETV	TDF(ABC) + 3TC (FTC) + EFV +LPV/r or ATV +RAL	TDF(ABC) + 3TC (FTC) + EFV or RPV TAF + FTC + LPV/r or DRV/c +DTG, RAL Co-formulated: TAF/FTC/EVG/c ABC/3TC/DTG
Alternatives	AZT(d4T) + 3TC + IDV ddI + d4T + EFV(NVP) AZT + ddI + EFV(NVP)	AZT + 3TC + NVP d4T + 3TC + NVP (Switch to AZT/ABC +3TC after 6 months)	AZT + 3TC + EFV or NVP or RPV	AZT + 3TC + EFV or NVP or RPV +LPV/r